摘要
近年来,生物医药产业已成为世界主要发达国家争相布局的重要领域,各国也相继出台了诸多加快产业发展的监管举措。本文将从国外鼓励创新研发、促进成果转化和加快创新产品上市等方面的举措展开研究,希望为今后在我国制定促进生物医药产业发展的监管制度提供借鉴与参考。
The biopharmaceutical industry has become an important area where the world’s major developed countries compete for layout,and many countries have introduced new regulatory measures to accelerate bio-industrial development in recent years.In this article,we focus on the study of measures adopted by foreign countries to encourage innovation and R&D,to promote the transformation of scientific and technological achievement and to accelerate product development process,hopefully to provide reference for the formulation of regulatory system in China so as to promote the development of the biomedical industry in the future.
作者
于玲莉
杨绎雯
刘朋
YU Lingli;YANG Yiwen;LIU Peng(Shanghai Center for Drug Evaluation and Inspection,Shanghai 201203,China;Shanghai Center for Adverse Drug and Medical Device Reaction Monitoring,Shanghai 200040,China)
出处
《上海医药》
CAS
2021年第17期53-55,共3页
Shanghai Medical & Pharmaceutical Journal
关键词
创新
药品监管
生物医药产业
innovation
drug regulation
biopharmaceutical industry